Hims & Hers Health (HIMS) Preferred Stock Liabilities (2019 - 2020)

Hims & Hers Health's (HIMS) quarterly Preferred Stock Liabilities came in at $250.0 million in Q4 2020, up 5454.71% year-on-year from $4.5 million in Q1 2020, and up 1.96% quarter-over-quarter from $245.2 million in Q3 2020.

Hims & Hers Health (HIMS) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

Hims & Hers Health has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $250.0 million for Q4 2020.

  • Preferred Stock Liabilities for Q4 2020 came in at $250.0 million, up 5454.71% year-over-year; the trailing twelve-month figure through Dec 2020 was $250.0 million (up 5454.71% YoY), and the FY2020 annual result was $250.0 million, up 5454.71% from the prior year.
  • Preferred Stock Liabilities came in at $250.0 million for Q4 2020 at Hims & Hers Health, up from $245.2 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $250.0 million in Q4 2020 to a low of $4.5 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 249.96 Mn
Sep 30, 2020 245.17 Mn
Jun 30, 2020 228.13 Mn
Mar 31, 2020 218.25 Mn
Dec 31, 2019 4.50 Mn